FDA
approval
· 2024-10-23
FDA Approved: NEVIRAPINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for Nevirapine from Camber Pharmaceuticals (ANDA078584), approving changes to the generic product under an existing …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEVIRAPINE (NEVIRAPINE)